Conventional research viewpoints are based on Paget's "seed and soil hypothesis". Previous studies that focused on the seed (cancer cells) emphasized the impact of molecular pathological changes of cancer cells on their biological behaviors including proliferation, invasion, and metastasis, [2] [3] [4] [5] [6] however, no specific markers that can explicitly predict tumor invasion and metastasis have been found so far. Recently, attention has been focused on the role of the soil (tumor microenvironment) in development of tumors, with studies on expression and function of relevant genes. 7, 8 Mesenchymal specific genes, which play important roles in the regulatory process, have closely linked the seed with the soil. 9, 10 Mesenchymal cells mainly express mesenchymal-specific genes with products that have various structures and functions, including secreted and extracellular matrix proteins. Periostin gene, which was originally cloned from a mouse osteoblastic cell line, is a newly identified mesenchymal specific gene. Early investigations revealed that periostin was related to the formation and maintenance of bones and teeth. Current studies of periostin mainly focus on two areas;
(a) facilitation of growth and development of heart valves, and its involvement in the pathophysiological processes of various ischemic heart diseases, including myocardial infarction and heart failure, (b) significant differential expressions of periostin mRNA and proteins between tumor and normal tissues, which implicate its close relationship with the occurrence, development, and prognosis of malignant tumors.
Periostin is a secreted extracellular matrix protein that is also called osteoblast-specific factor 2 (OSF-2). Functionally, it induces proliferation and differentiation of osteoblasts, as well as adhesion and aggregation of periosteal osteoblast precursor cells.
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It is expressed in various normal human tissues and plays a role in many normal physiological processes. Additionally, periostin is also associated with pathological processes, such as development of cardiovascular diseases, asthma, and cancer. 12 Currently, many studies indicate that the overexpression of periostin is related to tumor grade, but on the contrary, others have reported that periostin could inhibit invasion and metastasis of bladder cancer cells. 13, 14 Moreover, Kanno et al, 15 found that periostin had dual effects; the promotion and inhibition of pancreatic cancer. These findings suggest different biological effects of periostin in different tissues, which indicate the need for further studies on its complex and multiaspect functions.
RNA interference (RNAi) is the process of double-stranded RNA (dsRNA)-mediated post-transcriptional gene silencing with a high degree of specificity and effectiveness that makes it an ideal tool for gene therapy. 16 In this report, we show for the first time the establishment of a human LSCC nude mouse transplantation model that was used to investigate the knockdown of periostin by RNA interference. Fortyeight nude mice were randomly divided into six groups: unmanipulated control group; glucose solution control group; transfection reagent control group; nonspecific gene sequences control group;
periostin-siRNA high-dose (1.0 optical density-OD) treatment group; and periostin-siRNA low-dose (0.5 OD) treatment group.
Tumor growth was observed in each group, and the inhibitory rate (%) calculated. Routine pathological and electron microscopic examination were used to determine tumor apoptosis and proliferation.
Changes in periostin mRNA and protein levels were analyzed by qRT-PCR and ELISA respectively. This analysis enabled us to explore the possible mechanism of periostin in the development of human LSCC. 
| MATERIAL S AND ME THODS

| Materials
| Methods
| Culture and expansion of human LSCC AMC-HN-8 cells
Human LSCC AMC-HN-8 cells were cultured in Roswell Park
Memorial Institute (RPMI) 1640 medium containing 10% fetal bovine serum (FBS) at 37°C in 5% CO 2 . After 0.25% trypsin digestion and passage, logarithmic growth phase cells were used in the experiment. Cells were seeded in a sterile Petri dish and amplified to a sufficient quantity for the experiments.
| Tumor transplantation and animal groups
Forty-eight BALB/cA nu/nu mice were inoculated subcutaneously in the axillary region with 0.2 mL AMC-HN-8 cell suspension (8.7 × 10 6 cells). Tumors were allowed to grow to more than 100 mm 
| Electron microscopic examination of cellular apoptosis
Tumor tissues were precooled in 4% glutaraldehyde, fixed for over 
| Quantitative RT-PCR
Reverse transcription was performed with GoScript Reverse Transcription (RT) System (Promega) kit. Five microgram (5 μg) of RNA was reverse transcribed into cDNA in 20-μL reaction volume and stored at -80°C.
Quantitative PCR was performed in triplicate with GoTaq qPCR master mix (Promega) kit using the primers shown in Table 1 .
GAPDH was the internal reference gene and no template reaction To perform ELISA, the reagent was equilibrated at room temperature for 30 minutes. Hundred microliter (100 μL) samples or standard (0-400 ng/mL) were placed in test plate and incubated at 37°C for 2 hours. The liquid was discarded, and plates dried by spinning before incubation with 100 μL biotin labeled antibody at 
| Statistical methods
SPSS Statistics (Version 17.0; SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Data were presented as mean ± standard deviation. Between groups comparisons were made using the t-test, and multiple groups were compared using single factor analysis of variance. P < 0.05 was considered statistically significant.
| RE SULTS
| Observation and calculation of solid tumor inhibition rate
Macroscopically, tumors in the treatment groups were smaller than in control groups, with the reduction in size more obvious in the high-dose periostin-siRNA treatment group. The tumors in the treatment groups were spherical, smooth, pink, and soft while those in the control groups were large, had nodular surfaces and less central necrosis than in the treatment groups. The mean tumor weight and inhibition rate for each group are shown in Table 2 .
| Pathological changes in tumor tissues
The tumors generated in nude mice after subcutaneous injection of Electron microscopic examination of changes observed in the treatment and control groups revealed nuclear chromatin demonstrating an "edge-set" phenomenon, accompanied by necrosis that was more marked in the high-dose periostin-siRNA treatment group (Figure 2 ).
| Periostin mRNA expressional changes in tumor tissue
The effect of periostin-siRNA on the expression of periostin mRNA in human LSCC AMC-HN-8 nude mouse transplanted tumors was significant. Periostin mRNA expression was significantly reduced in the treatment groups compared to the control groups (P < 0.05). The differential expression was also statistically significant (P < 0.05) between the high-and low-dose periostin-siRNA treatment groups. There were no significant differences among the control groups ( Figure 3 ). 
Groups
| Periostin protein expression in tumor tissue
Periostin protein expression was significantly reduced in the treatment groups, compared to control groups (P < 0.05). The difference was statistically significant (P < 0.05) between the high-dose periostin-siRNA treatment group and the control and low-dose periostin-siRNA treatment groups. No significant differences were found among the control groups ( Figure 4 ).
| D ISCUSS I ON
Periostin is highly expressed in multiple solid tumor tissues, including head and neck carcinoma, lung, breast, colorectal, ovarian, and liver Periostin-integrin pathway regulates breast cancer development and tumor microenvironment at multiple levels. Periostin-binding DNA aptamer-3 (PNDA-3) is a potential target to inhibit the development of breast cancer. 18 Choi et al can also form metastases in the corresponding site to avoid false positive results due to the site-specificity of transplantation, [24] [25] [26] [27] but the technical requirements are high. After consulting a large number of relevant literature, there are orthotopic transplantation tumor animal models which cover liver cancer, lung cancer, cervical cancer, bladder cancer, ovarian cancer etc., but we did not find laryngeal carcinoma orthotopic transplantation tumor animal models. Therefore, for the next step we will study laryngeal carcinoma 
| CON CLUS IONS
Great progress has been achieved on the role of periostin in the oc- 
